FDA Approved: FLUTICASONE PROPIONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Fluticasone Propionate from Hikma Pharmaceuticals USA Inc., under the ANDA program.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)

Snippet

SUPPL AP for FLUTICASONE PROPIONATE (FLUTICASONE PROPIONATE)